Last updated: 11/04/2018 12:47:02

Enamel Remineralization Potential of Dentifrices in situ

GSK study ID
T3500690
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Completed
Completed
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Comparison of enamel remineralization potential of dentifrices incorporating different fluoride salts using an in situ caries model
Trial description: This study will use an oral in-situ caries model to study remineralization of enamel due to the action of different combinations of fluoride salts delivered from dentifrices.
Primary purpose:
Prevention
Trial design:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Allocation:
Randomized
Primary outcomes:

Percentage surface microhardness recovery (%SMHR) of enamel specimens exposed to NaF toothpaste (1450ppmF) and SnF/NaF toothpaste (1450ppmF)

Timeframe: Baseline to 14 days

Secondary outcomes:

%SMHR of enamel specimens exposed to NaF toothpaste (1450ppmF), SnF/NaF toothpaste (1450ppmF), NaMFP/NaF toothpaste (1450ppmF) and NaF toothpaste (675ppmF)

Timeframe: Baseline to 14 days

Change from baseline in enamel fluoride uptake upon exposure to NaF toothpaste (1450ppmF), SnF/NaF toothpaste (1450ppmF), NaMFP/NaF toothpaste (1450ppmF) and NaF toothpaste (675ppmF)

Timeframe: Baseline to 14 days

Interventions:
Drug: NaF
Drug: SnF
Drug: NaMFP
Enrollment:
83
Observational study model:
Not applicable
Primary completion date:
2010-31-03
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
dental caries
Product
sodium fluoride
Collaborators
Not applicable
Study date(s)
November 2009 to April 2010
Type
Interventional
Phase
4

Participation criteria

Sex
Female & Male
Age
18 - 80 years
Accepts healthy volunteers
Yes
  • Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical or oral health.
  • No current active caries or periodontal disease that may compromise the study or health of the subject.
  • Individuals currently taking antibiotics, or who have taken antibiotics within 30 days prior to the first treatment visit.
  • Current active caries or periodontal disease that may compromise the study or health of the subject.

Trial location(s)

Location
Status
Contact us
Contact us
Location
Indiana University School of Dentistry
Indianapolis, IN, United States, 46202
Status
Study Complete

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Results posted on ClinicalTrials.gov

Recruitment status
Completed
Actual primary completion date
2010-31-03
Actual study completion date
2010-01-04

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website